(Q46464086)

22 December 2017

title

Potential for combination therapy with the new antiserotonergic agents (English)

1 reference

22 December 2017

author name string

Grunberg SM

series ordinal

1

1 reference

22 December 2017

publication date

1 January 1993

1 reference

22 December 2017

European Journal of Cancer

published in

1 reference

22 December 2017

volume

29A Suppl 1

1 reference

22 December 2017

page(s)

S39-41

1 reference

22 December 2017

The control of chemotherapy-induced emesis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Antiemetics: neurotransmitter receptor binding predicts therapeutic actions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Blockade of neuronal tryptamine receptors by metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

ONDANSETRON WITH AND WITHOUT DEXAMETHASONE TO TREAT CHEMOTHERAPY-INDUCED EMESIS

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Potential use of drugs modulating 5HT activity in the treatment of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

The 5-HT3 antagonist, BRL 43694, does not compromise the efficacy of cisplatin in tumour-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980260-6

7 January 2021

10.1016/S0959-8049(05)80260-6

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017